Detalles de la búsqueda
1.
Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma.
Ann Surg Oncol
; 30(5): 2782-2790, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36178565
2.
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study.
BMC Cancer
; 23(1): 416, 2023 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37158833
3.
ASO Visual Abstract: Hepatectomy Following Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy in Patients with Unresectable Hepatocellular Carcinoma.
Ann Surg Oncol
; 30(5): 2791-2792, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36869918
4.
High platelet counts increase metastatic risk in huge hepatocellular carcinoma undergoing transarterial chemoembolization.
Hepatol Res
; 46(10): 1028-36, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26776560
5.
Imbalance in systemic inflammation and immune response following transarterial chemoembolization potentially increases metastatic risk in huge hepatocellular carcinoma.
Tumour Biol
; 36(11): 8797-803, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26058874
6.
The platelet-to-lymphocyte ratio predicts poor survival in patients with huge hepatocellular carcinoma that received transarterial chemoembolization.
Tumour Biol
; 36(8): 6045-51, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25731733
7.
Sex-determination gene SRY potentially associates with poor prognosis but not sex bias in hepatocellular carcinoma.
Dig Dis Sci
; 60(2): 427-35, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25274159
8.
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study.
Signal Transduct Target Ther
; 8(1): 106, 2023 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36928584
9.
[Evaluation of the efficacy and prognostic factors for colorectal liver metastases treated with transcatheter arterial chemoembolization].
Zhonghua Zhong Liu Za Zhi
; 34(9): 706-9, 2012 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-23159087
10.
Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysis.
Biomark Res
; 9(1): 19, 2021 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33743822
11.
Development of a Prognostic Scoring System for Hepatocellular Carcinoma Patients With Main Portal Vein Tumor Thrombus Undergoing Conventional Transarterial Chemoembolization: An Analysis of 173 Patients.
Front Oncol
; 11: 671171, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34513667
12.
Hepatic Arterial Infusion Chemotherapy with Modified FOLFOX as an Alternative Treatment Option in Advanced Hepatocellular Carcinoma Patients with Failed or Unsuitability for Transarterial Chemoembolization.
Acad Radiol
; 28 Suppl 1: S157-S166, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33653656
13.
Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations.
Liver Cancer
; 10(4): 320-329, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34414120
14.
A new prediction model for prognosis of patients with intermediate-stage HCC after conventional transarterial chemoembolization: an internally validated study.
J Cancer
; 10(26): 6535-6542, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31777583
15.
[Treatment of postoperative recurrence of hepatocellular carcinoma with radiofrequency ablation comparing with repeated surgical resection].
Zhonghua Wai Ke Za Zhi
; 46(21): 1614-6, 2008 Nov 01.
Artículo
en Zh
| MEDLINE | ID: mdl-19094752
16.
Hepatitis B surface antigen predicts recurrence after radiofrequency ablation in patients with low hepatitis B virus loads.
Medicine (Baltimore)
; 96(52): e9377, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29384914
17.
[Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
Zhonghua Zhong Liu Za Zhi
; 27(6): 380-2, 2005 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-16117905
18.
Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma.
World J Gastroenterol
; 21(13): 3970-7, 2015 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25852283
19.
Prevention of hepatocellular carcinoma in mice by IL-2 and B7-1 genes co-transfected liver cancer cell vaccines.
World J Gastroenterol
; 9(10): 2182-5, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-14562374
20.
[Prospective randomized trial of RFA and chemotherapy for unresectable small hepatocellular carcinoma].
Zhonghua Zhong Liu Za Zhi
; 26(8): 496-8, 2004 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-15555343